Community-acquired Pneumonia Clinical Trials

18 recruiting

Community-acquired Pneumonia Trials at a Glance

22 actively recruiting trials for community-acquired pneumonia are listed on ClinicalTrialsFinder across 6 cities in 45 countries. The largest study group is Phase 3 with 7 trials, with the heaviest enrollment activity in Hamilton, Toronto, and Calgary. Lead sponsors running community-acquired pneumonia studies include Jeffrey, Chinese University of Hong Kong, and Biotest.

Browse community-acquired pneumonia trials by phase

Treatments under study

About Community-acquired Pneumonia Clinical Trials

Looking for clinical trials for Community-acquired Pneumonia? There are currently 18 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Community-acquired Pneumonia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Community-acquired Pneumonia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 22 trials

Recruiting
Not Applicable

Noninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia

Community-acquired PneumoniaCommunity-Acquired Infections
Assiut University100 enrolled1 locationNCT06996834
Recruiting
Not Applicable

PromotIng Optimal Treatment for Community-acquired PNeumonia in EmErgency Rooms

PneumoniaCommunity-Acquired Pneumonia (CAP)
Jeffrey Pernica698 enrolled6 locationsNCT07099976
Recruiting
Phase 3

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Community-acquired Pneumonia
University of Manitoba4,000 enrolled64 locationsNCT05848713
Recruiting
Phase 3

Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward

Community-acquired Pneumonia
Nantes University Hospital326 enrolled19 locationsNCT06229288
Recruiting
Phase 3

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

Community-acquired Pneumonia
Biotest590 enrolled147 locationsNCT05722938
Recruiting
Not Applicable

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care

AnginaAcute BronchiolitisAcute Bronchitis+8 more
University Hospital, Caen4,500 enrolled1 locationNCT07359287
Recruiting
Phase 3

Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)

Community-acquired Pneumonia
Hellenic Institute for the Study of Sepsis330 enrolled24 locationsNCT06294600
Recruiting

The Fever Clinic Acute Respiratory Cohort

Community-acquired PneumoniaFebrile IllnessesViral Respiratory Tract Infections+1 more
Fudan University1,000 enrolled1 locationNCT07278700
Recruiting
Phase 4

Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

Community-acquired Pneumonia
Mayo Clinic1,120 enrolled5 locationsNCT07164131
Recruiting
Phase 4

The Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Practice in Denmark (CAP-D)

Community-acquired Pneumonia
Research Unit for General Practice in Aalborg600 enrolled1 locationNCT06295120
Recruiting
Not Applicable

Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia

COPD Exacerbation AcuteCommunity-acquired Pneumonia
University of Vermont8 enrolled1 locationNCT05452226
Recruiting
Phase 2

Efficacy and Safety of SR1375 in Adult Patients With CAP

Community-acquired Pneumonia
Shanghai SIMR Biotechnology Co., Ltd.240 enrolled29 locationsNCT06577558
Recruiting
Phase 2Phase 3

Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.

Community-acquired Pneumonia
St. Justine's Hospital1,370 enrolled1 locationNCT03031210
Recruiting
Not Applicable

High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia

Community-acquired PneumoniaNosocomial Pneumonia
Tomsk National Research Medical Center of the Russian Academy of Sciences200 enrolled1 locationNCT06170372
Recruiting

Evaluation of Streptococcus Pneumoniae Serotypes Prevalence Using a Urinary Kit

Community-acquired Pneumonia
Chinese University of Hong Kong1,800 enrolled1 locationNCT04647630
Recruiting
Phase 4

Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Short-course Therapy

Community-acquired Pneumonia
Jeffrey75 enrolled1 locationNCT06125340
Recruiting
Not Applicable

Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Novel Diagnostics

Community-acquired Pneumonia
Jeffrey75 enrolled1 locationNCT06114888
Recruiting

Fulminant Severe CAP - an Observational Study

SepsisARDS, HumanCommunity-acquired Pneumonia+1 more
University of Trieste1,460 enrolled2 locationsNCT06516601
Recruiting
Phase 3

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Community-acquired Pneumonia, Influenza, COVID-19
UMC Utrecht20,000 enrolled408 locationsNCT02735707
Recruiting

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years

InfluenzaCardiovascular EventsCommunity-acquired Pneumonia
Kaiser Permanente960,000 enrolled1 locationNCT06029933